Dual Roles of Diadenosine Polyphosphates in Corneal Epithelial Cell Migration
Overview
Affiliations
Purpose: To investigate the influence of diadenosine polyphosphates on the rate of corneal epithelial cell migration.
Methods: Primary corneal epithelial cell cultures were obtained from New Zealand White rabbits. Immunocytochemical experiments were performed by fixing the cells with 4% paraformaldehyde (PFA) and incubated with cytokeratin 3 primary antibody, which was subsequently incubated with a secondary IgG mouse labeled with FITC, and the cells were observed under confocal microscopy. Migration studies were performed by taking confluent monolayers that were wounded with a pipette tip and challenged with different di- and mononucleotides with or without P2 antagonist (n = 8 each treatment). For concentration-response analysis, compounds were tested in doses ranging from 10(-8) to 10(-3) M (n = 8). The stability of the dinucleotides was assayed by HPLC, with an isocratic method (n = 4).
Results: Cells under study were verified as corneal epithelial cells via the immunocytochemical analysis. Cell migration experiments showed that Ap4A, UTP, and ATP accelerated the rate of healing (5, 2.75, and 3 hours, respectively; P < 0.05; P < 0.001), whereas Ap3A, Ap5A, and UDP delayed it (6.5, 10, and 2 hours, respectively; P < 0.05). ADP did not modify the rate of migration. Antagonists demonstrated that Ap4A and Ap3A did activate different P2Y receptors mediating corneal wound-healing acceleration and delay. Concerning the possible degradation of the dinucleotides, it was almost impossible to detect any products resulting from their cleavage.
Conclusions: Based on the pharmacological profile of all the compounds tested, the two main P2Y receptors that exist in these corneal cells are a P2Y(2) receptor accelerating the rate of healing and a P2Y6 receptor that delays this process.
Carpena-Torres C, Pintor J, Huete-Toral F, Martin-Gil A, Rodriguez-Pomar C, Martinez-Aguila A Int J Mol Sci. 2021; 22(21).
PMID: 34769429 PMC: 8584318. DOI: 10.3390/ijms222111999.
Ocular Purine Receptors as Drug Targets in the Eye.
Jacobson K, Civan M J Ocul Pharmacol Ther. 2016; 32(8):534-547.
PMID: 27574786 PMC: 5069731. DOI: 10.1089/jop.2016.0090.
A comparison of epithelial-to-mesenchymal transition and re-epithelialization.
Leopold P, Vincent J, Wang H Semin Cancer Biol. 2012; 22(5-6):471-83.
PMID: 22863788 PMC: 3595494. DOI: 10.1016/j.semcancer.2012.07.003.
Nucleotide receptors as targets in the pharmacological enhancement of dermal wound healing.
Gendaszewska-Darmach E, Kucharska M Purinergic Signal. 2011; 7(2):193-206.
PMID: 21519856 PMC: 3146642. DOI: 10.1007/s11302-011-9233-z.
The P2Y2 receptor mediates the epithelial injury response and cell migration.
Boucher I, Rich C, Lee A, Marcincin M, Trinkaus-Randall V Am J Physiol Cell Physiol. 2010; 299(2):C411-21.
PMID: 20427708 PMC: 2928627. DOI: 10.1152/ajpcell.00100.2009.